A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Shu Wang et al.|Cell|2018Cited by 1.5k
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Eytan Ruppin, Gao Zhang et al.|Nature Medicine|2018Cited by 813
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Genevieve M. Boland, Jia‐Ren Lin et al.|Nature Medicine|2021Cited by 135
Abstract SY45-04: Development of therapeutic strategies by resolving the tumor ecosystemBenjamin Izar, Aviv Regev, Livnat Jerby‐Arnon et al.|Clinical Research (Excluding Clinical Trials)|2019Cited by 0
Abstract SY45-04: Development of therapeutic strategies by resolving the tumor ecosystemBenjamin Izar, Aviv Regev, Livnat Jerby‐Arnon et al.|Cancer Research|2019Cited by 0